MacroGenics
MGNX
139 hedge funds and large institutions have $1.33B invested in MacroGenics in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 16 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 46
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
1% more funds holding
Funds holding: 137 → 139 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less call options, than puts
Call options by funds: $2.91M | Put options by funds: $2.92M
4.96% less ownership
Funds ownership: 104.64% → 99.68% (-5%)
7% less capital invested
Capital invested by funds: $1.42B → $1.33B (-$93.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$61M |
| 2 |
State Street
Boston,
Massachusetts
|
+$20.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.9M |
| 4 |
BlackRock
New York
|
+$8.31M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$7.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$14M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$8.03M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$5.94M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.72M |
MGNX Hedge Fund Activity: Q3 2020 in Review
139 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2020, worth a combined $1.33B — down 6.6% from $1.42B a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new MGNX positions and 16 closed out — a net gain of 2 holders — while 56 added to existing stakes and 46 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $61M. The largest seller was Millennium Management, cutting an estimated $14M.
- 139 institutional investors held MacroGenics (MGNX) as of Q3 2020, up from 137 in Q2 2020.
- Funds reported $1.33B of MacroGenics stock for Q3 2020, down 6.6% quarter-over-quarter.
- 18 funds opened new MacroGenics positions in Q3 2020 and 16 closed out, a net change of +2 holders.
- The largest MacroGenics buyer in Q3 2020 was Point72 Asset Management, an estimated $61M added.
- The largest MacroGenics seller in Q3 2020 was Millennium Management, an estimated $14M sold.
Based on aggregated 13F filings for Q3 2020.